Lv4
709 积分 2021-01-18 加入
Clinical Breakthrough in Targeted Protein Degradation: Reflections on the Approval of ARV‐471
2天前
已完结
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
11天前
已完结
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
16天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
23天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
24天前
已完结
(BDP)CuH: A “Hot” Stryker's Reagent for Use in Achiral Conjugate Reductions
27天前
已完结
RAS-ing the bar in the treatment of KRAS-mutant cholangiocarcinoma
1个月前
已完结
Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis
1个月前
已完结
Rational Design of Small-Molecule Stabilizers of Human Fumarylacetoacetate Hydrolase for the Treatment of Tyrosinemia Type I
1个月前
已完结
Targeted Degradation of Prolyl Hydroxylase Domain Enzyme 1 (PHD1) as a Novel Therapeutic Strategy for Acetaminophen-Induced Acute Liver Injury
1个月前
已完结
皖公网安备34019202002308
